Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Weijun Wei

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Molecular Pharmaceutics|August 4, 2022
Voices in Molecular Pharmaceutics: Meet Dr. Weijun Wei Who Is Developing Theranostic Nuclear Medicine Agents for Clinical UseWeijun Wei
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2023
Theranostics Is Not RadiotheranosticsWeijun Wei
European Journal of Nuclear Medicine and Molecular Imaging|August 2, 2022
[<sup>64</sup>Cu]Cu-ATSM: an emerging theranostic agent for cancer and neuroinflammationFang Xie, Weijun Wei
European Journal of Nuclear Medicine and Molecular Imaging|August 30, 2023
Molecular imaging for better theranosticsDawei Jiang, Weijun Wei
American Journal of Nuclear Medicine and Molecular Imaging|July 8, 2021
Advancing the diagnosis of epithelioid hemangioendothelioma by <sup>18</sup>F-FDG PET/CTWeijun Wei, Gang Huang, Jianjun Liu
Med (New York, N.Y.)|April 18, 2025
CD70-targeted cancer theranostics: Progress and challengesWeijun Wei, Viktor Grünwald, Ken Herrmann
American Journal of Nuclear Medicine and Molecular Imaging|November 24, 2022
Rare pulmonary metastases of atypical meningioma diagnosed on total-body <sup>18</sup>F-FDG PET/CTQing Wang, Weijun Wei, Min Cao
Endocrine-Related Cancer|January 23, 2019
Targeting autophagy in thyroid cancersWeijun Wei, Heather Hardin, Quan-Yong Luo
Molecular Pharmaceutics|October 3, 2022
Antibody-Based Imaging and Therapy for Precision MedicineWeijun Wei, Dawei Jiang, Laura Evangelista, et al.
Drug Discovery Today|November 28, 2021
ImmunoPET imaging of hematological malignancies: From preclinical promise to clinical realityYiting Dun, Gang Huang, Jianjun Liu, et al.
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Molecular Pharmaceutics|August 4, 2022
Voices in Molecular Pharmaceutics: Meet Dr. Weijun Wei Who Is Developing Theranostic Nuclear Medicine Agents for Clinical UseWeijun Wei
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 19, 2023
Theranostics Is Not RadiotheranosticsWeijun Wei
European Journal of Nuclear Medicine and Molecular Imaging|August 2, 2022
[<sup>64</sup>Cu]Cu-ATSM: an emerging theranostic agent for cancer and neuroinflammationFang Xie, Weijun Wei
European Journal of Nuclear Medicine and Molecular Imaging|August 30, 2023
Molecular imaging for better theranosticsDawei Jiang, Weijun Wei
American Journal of Nuclear Medicine and Molecular Imaging|July 8, 2021
Advancing the diagnosis of epithelioid hemangioendothelioma by <sup>18</sup>F-FDG PET/CTWeijun Wei, Gang Huang, Jianjun Liu
Med (New York, N.Y.)|April 18, 2025
CD70-targeted cancer theranostics: Progress and challengesWeijun Wei, Viktor Grünwald, Ken Herrmann
American Journal of Nuclear Medicine and Molecular Imaging|November 24, 2022
Rare pulmonary metastases of atypical meningioma diagnosed on total-body <sup>18</sup>F-FDG PET/CTQing Wang, Weijun Wei, Min Cao
Endocrine-Related Cancer|January 23, 2019
Targeting autophagy in thyroid cancersWeijun Wei, Heather Hardin, Quan-Yong Luo
Molecular Pharmaceutics|October 3, 2022
Antibody-Based Imaging and Therapy for Precision MedicineWeijun Wei, Dawei Jiang, Laura Evangelista, et al.
Drug Discovery Today|November 28, 2021
ImmunoPET imaging of hematological malignancies: From preclinical promise to clinical realityYiting Dun, Gang Huang, Jianjun Liu, et al.
Pageof 10